MYP_119382
Basic Information
Palivizumab
Antimicrobial
Antiviral
Antiviral Anti-Pneumovirus Anti-RSV
Immunology Immune modulation Immunomodulatory activity
Standard
120 amino acids
C597H926N154O182S5
Standard
Sequence
QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMSVGWIRQPPGKALEWLADIWWDDKKDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCARSMITNWYFDVWGAGTTVTVSS
Physicochemical Analysis
13332.99 Da
8.62
1.74
1.48
0.0145
-0.26
0.52
0.05
20.34
73.08
0.1083
38960.00
39085.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
5409.29
-57.61
194.0
189.0
426.0
938.0
25.0
127.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0120834 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Monoclonal antibody
9606
Structure & Mods
branched peptide architecture [Branched]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Anti-RSV Neutralizing antibody
Respiratory syncytial virus
Clinical trial
RECORD: Rec_0295627 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]; Mus musculus [Animal]
Monoclonal antibody
9606;10090
Structure & Mods
linear peptide/protein therapeutic [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial Antiviral Immunomodulatory
18-20 days (in adults)
RECORD: Rec_0418844 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; Mus musculus [Animal]
Monoclonal antibody
9606;10090
Structure & Mods
linear multidomain protein biologic [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Anti-RSV Passive immunization
Respiratory syncytial virus
18-20 d (in adults)